43 unknown. 43 Phase 2, 7 Phase 1, 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 43 | Unknown 43 |
| Phase 1 | 7 | Unknown 7 |
| Phase 3 | 6 | Unknown 6 |
Follow Vector Borne Diseases: new trials by email Literature Review of Vector Borne Diseases trials Research Report on Vector Borne Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sm-p80 Schistosomiasis Challenge Study Sm-p80 + GLA-SE Vaccine, Placebo, Schistosoma mansoni infection - Schistosoma Mansoni, Schistosomiasis | Phase 2 | Unknown | Leiden University Medical Center | 48 | 2024-09-01 | 2023-10-17 |
| Early Interferon-beta Treatment for West-Nile Virus Infection Rebif 44 MCG Per 0.5 ML Prefilled Syringe, Saline - West Nile Virus, West Nile Fever Encephalitis | Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 100 | 2024-07-14 | 2024-07-23 |
| Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis Oral tofacitinib, Parenteral meglumine antimoniate - Cutaneous Leishmaniasis, American | Phase 2 / Phase 3 | Unknown | Hospital Universitário Professor Edgard Santos | 22 | 2023-10-01 | 2023-08-25 |
| Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome Arm-2 : 2,00,000 IU Vitamin D3 oral solution , Arm-3: 4,00,000 IU Vitamin D3 oral solution - Dengue Fever | Phase 2 | Unknown | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 120 | 2023-06-01 | 2023-10-06 |
| MSP3-CRM-Vac4All/ Alhydrogel® Vaccine MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine - Malaria,Falciparum | Phase 1 / Phase 2 | Unknown | Vac4All | 465 | 2023-03-27 | 2023-04-26 |
| An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity Stamaril, Imojev, Ixiaro - Infectious Disease, Yellow Fever | Phase 2 | Unknown | Singapore General Hospital | 70 | 2022-09-28 | 2023-04-12 |
| Anti-Schistosomiasis Sm14-vaccine in Senegal Sm14 recombinant vaccine+ GLA-SE adjuvant - Schistosomiasis Mansoni, Schistosomiasis Haematobium | Phase 2 | Unknown | Oswaldo Cruz Foundation | 120 | 2022-07-01 | 2022-12-21 |
| Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly Miltefosine 50mg, Pentoxifylline 400mg, Liposomal Amphotericin B - Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous | Phase 2 / Phase 3 | Unknown | University of Brasilia | 100 | 2022-06-22 | 2023-09-15 |
| Emodepside Phase II Trial for Treatment of Onchocerciasis emodepside, matching placebo of emodepside, ivermectin - Onchocerciasis | Phase 2 | Unknown | Drugs for Neglected Diseases | 578 | 2021-08-30 | 2024-03-05 |
| SBRT in Chagas Disease Ventricular Tachycardia Stereotactic Body Radiation Therapy - Ventricular Tachycardia, Chagas Disease | Phase 1 / Phase 2 | Unknown | University of Sao Paulo General Hospital | 10 | 2021-07-14 | 2024-07-16 |
| Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune Volunteers Vaccine PvCS N+C+R 150 mcg, Placebo SSN Montanide ISA-51 1 mL - Malaria, Vivax | Phase 2 | Unknown | Malaria Vaccine and Drug Development Center | 120 | 2021-06-01 | 2021-03-01 |
| Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients 18-Methoxycoronaridine, Glucantime - Leishmaniasis; American, Cutaneous, Drug Side Effect | Phase 2 | Unknown | Infan Industria Quimica Farmaceutica Nacional | 52 | 2021-05-01 | 2020-03-19 |
| Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension Selexipag - Pulmonary Hypertension, Schistosomiasis | Phase 2 | Unknown | University of Sao Paulo General Hospital | 20 | 2020-10-15 | 2020-10-19 |
| Immunogenicity and Safety of Subunit Vaccine of Plague Vaccine With Two Immunization Regimens plague vaccine(F1+rV) - Plague | Phase 2 | Unknown | Jiangsu Province Centers for Disease Control and Prevention | 720 | 2020-05-08 | 2022-04-15 |
| Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections Pyronaridine tetraphosphate 180mg:artesunate 60mg - Malaria,Falciparum | Phase 2 | Unknown | Shin Poong Pharmaceutical Co. Ltd. | 300 | 2018-10-03 | 2019-09-30 |
| Colchicine for Patients With Chagas´ Disease( B1 Stage) Colchicine 0.5 MG twice day for one year, Placebo Oral Tablet - Chagas Disease, Colchicine Resistance | Phase 2 | Unknown | University of Sao Paulo General Hospital | 60 | 2018-10-01 | 2019-03-11 |
| Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites Imatinib, Dihydroartemisinin-piperaquine - Plasmodium Falciparum Malaria (Drug Resistant) | Phase 2 | Unknown | Nurex S.r.l. | 50 | 2017-09-17 | 2018-10-05 |
| BENDITA BEnznidazole New Doses Improved Treatment and Associations Benznidazole, E1224, E1224 Placebo - Chagas Disease | Phase 2 | Unknown | Drugs for Neglected Diseases | 210 | 2016-11-30 | 2017-12-20 |
| Plasmodium Immunotherapy for Lung Cancer Blood-stage infection of P. vivax - Lung Cancer, Nonsmall Cell | Phase 1 / Phase 2 | Unknown | State Key Laboratory of Respiratory Disease | 30 | 2016-06-27 | 2023-06-22 |
| Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine Western Equine Encephalitis (WEE) Vaccine - Western Equine Encephalitis | Phase 2 | Unknown | U.S. Army Medical Research and Development Command | 500 | 2015-12-15 | 2021-02-11 |
Showing 20 of 43. Sign in to see all of them.
Malaria (8) · Chagas Disease (6) · Dengue (5) · Malaria, Falciparum (5) · Leishmaniasis, Mucocutaneous (4) · Encephalitis (3) · Leishmaniasis (3) · Leishmaniasis, Cutaneous (3) · Encephalitis, Japanese (2) · Encephalomyelitis, Venezuelan Equine (2) · Malaria, Vivax (2) · Schistosomiasis (2) · Virus Diseases (2) · Alphavirus Infections (1) · Arrhythmias, Cardiac (1)
Infections (42) · Parasitic Diseases (27) · Protozoan Infections (24) · Mosquito-Borne Diseases (23) · Arbovirus Infections (13) · Euglenozoa Infections (13) · RNA Virus Infections (13) · Virus Diseases (11) · Flaviviridae Infections (9) · Flavivirus Infections (9) · Central Nervous System Diseases (8) · Central Nervous System Infections (8) · Skin and Connective Tissue Diseases (8) · Brain Diseases (7)
Meglumine Antimoniate (4) · benzonidazole (3) · miltefosine (3) · Ivermectin (2) · Pentoxifylline (2) · Prodrugs (2) · Ribavirin (2) · Vaccines (2) · fosmidomycin (2) · 18-methoxycoronaridine (1) · Aluminum Hydroxide (1) · Artesunate (1) · Azithromycin (1) · Bay 44-4400 (1) · Chloroquine (1)
Drugs for Neglected Diseases (4) · U.S. Army Medical Research and Development Command (4) · University of Sao Paulo General Hospital (3) · Oswaldo Cruz Foundation (2) · University of Brasilia (2) · Vac4All (2) · African Malaria Network Trust (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Butantan Institute (1) · Centre Hospitalier Universitaire de la Guadeloupe (1) · Centro de Investigaciones Bioclínicas de la Fundación Fader (1) · Claude Bernard University (1) · Elisabethinen Hospital (1) · Guangzhou 8th People's Hospital (1) · Hadassah Medical Organization (1)
Brazil (9) · Bolivia (4) · United States (4) · China (3) · Mali (3) · Colombia (2) · Israel (2) · Thailand (2) · Austria (1) · Bangladesh (1) · Czechia (1) · Democratic Republic of the Congo (1) · France (1) · Gabon (1) · Ghana (1)
Anthony Cardile, DO (3) · Faustino Torrico, PhD (2) · Alexander R Precioso, MD, PhD (1) · Armando O. Schubach, MD, PhD (1) · Benedito AL Fonseca, PhD (1) · Caio J Fernandes, PHD (1) · Claes D Enk, MD, PhD (1) · Clara Menendez, MD, PhD (1) · Fabio Fernandes, Md, PHD (1) · Faustino Torrico, MD (1) · Fengcai Zhu, Master (1) · Francesco M Turrini, MD, PhD (1)
PMID 15714427, PMID 18419347, PMID 19143532, PMID 19630971, PMID 21292874, PMID 21931708, PMID 29352704, PMID 30509941, PMID 31307503, PMID 32220283, PMID 33124646, PMID 33763778, PMID 33836161, PMID 33983371, PMID 35837409, PMID 35925555, PMID 36409773, PMID 36780676, PMID 36969244, PMID 39308445, PMID 39356094, PMID 39627222, PMID 39794472, PMID 40982532
2014 (1)